How could the examination of wearable technology affect the National Institute for Health and Care Excellence?
NICE may need to evaluate smart glasses' clinical benefit for NHS use The examination of wearable technology, such as smart glasses, by the National Health Service and the Department for Education could lead to a need for formal clinical evaluation. Since smart glasses have been acknowledged as having huge benefits for blind and partially sighted people, the NHS would need to determine if the technology is safe and cost-effective for widespread adoption. The National Institute for Health and Care Excellence is the body responsible for producing the recommendations that the NHS must follow regarding the implementation of new technologies.
- Effect
- Mixed
- How direct
- Brind's reasoning
- When
- Within months
- The story
- No new developments lately
How it reaches National Institute for Health and Care Excellence
-
The National Health Service and the Department for Education are examining wearable technology. This follows a parliamentary debate where MPs warned that smart glasses are being used to profit from filming women and girls without their consent. Labour's Satvir Kaur stated that ministers are reviewing options to restrict smart glasses in certain settings and for certain users.
The full event1independent outlet -
If the NHS determines that wearable technology offers significant clinical benefits, such as aiding blind and partially sighted people, it must follow established procedures for adoption. The National Institute for Health and Care Excellence is the body that evaluates the cost and clinical benefit of such technologies before they can be implemented by the NHS.
No report states this step directly. Brind drew it from the reporting on each side of it, so treat it as an informed guess.
-
non-departmental public body of the Department of Health in the United Kingdom
Everything about National Institute for Health and Care Excellence
Tap any step to see the evidence behind it.
The facts so far
As reported. Each one links to where it comes from.
Why it matters
For the National Institute for Health and Care Excellence, the evaluation of new technologies is central to its mandate, ensuring that public funds are spent effectively and that clinical standards are maintained. If smart glasses move from a general examination phase to a consideration for clinical deployment, NICE would need to assess the technology's efficacy, safety, and cost-effectiveness against existing care pathways.
This process is crucial because the NHS must adhere to NICE recommendations for implementation. The debate around smart glasses is not just about privacy, but also about how new technology can be safely and beneficially integrated into the healthcare system, requiring a rigorous assessment of its value.
What we don't know yet
- What specific clinical applications of wearable technology are the NHS and DoE currently examining?
- What criteria will NICE use to assess the cost-effectiveness of smart glasses?
What would change this answer
Who else could feel it
Other possible ripples from the same event.
- Palantir TechnologiesPossiblePalantir may need to adapt its NHS data platforms for wearable technology
- British Medical AssociationPossibleBMA may influence standards for wearable technology use in NHS
- UK Health Security AgencyPossibleUKHSA may advise on health and safety protocols for educational wearable technology
- Department of Health and Social CarePossibleDepartment of Health and Social Care may need to set new regulatory guidance for wearable technology
Reporting
- aol.comFriday
Keep going
Brind's analysis is written by AI from the reporting linked above and can be wrong. This explainer is a possibility worth considering, not a forecast: steps marked as Brind's reasoning are not stated in the reporting. It is not investment advice; do your own research.